Rocket Pharmaceuticals, Inc. logo RCKT - Rocket Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 13
HOLD 4
SELL 2
STRONG
SELL 0
| PRICE TARGET: $5.00 DETAILS
HIGH: $5.00
LOW: $5.00
MEDIAN: $5.00
CONSENSUS: $5.00
UPSIDE: 68.92%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 6.38
Quick Ratio 6.38
Solvency Ratio -3.985
Cash Ratio 2.57

Valuation Ratios

Ratio Value
Price/Earnings
-1.75
Peers avg: 21.6
PEG Ratio 0.07
Forward PEG 0.07
Price/Book 1.41
Price/Sales 0.00
Price/FCF -2.05
Price/Op Cash Flow -2.05

Debt Ratios

Ratio Value
Debt/Assets 0.0753
Debt/Equity 0.0897
Debt/Capital 0.0823
Long-Term Debt/Capital 0.0000
Financial Leverage 1.19

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -6.291
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.2%

Coverage Ratios

Ratio Value
Debt Service Coverage -43.74
Interest Coverage -120.8440
Short-Term Operating Cash Flow Coverage -65.18
Operating Cash Flow Coverage -7.64
Capital Expenditure Coverage -431.85
Dividend + Capital Expenditure Coverage -431.85

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -2.008
Debt/Share 0.2409
Cash/Share 1.70
Book Value/Share 2.49
Tangible BV/Share 1.92
Equity/Share 2.49
Operating Cash Flow/Share -1.710
Capital Expenditure/Share 0.004
FCF/Share -1.714

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.976
Price/Fair Value 1.41
Debt/Market Cap 0.0075
Effective Tax Rate 0.0%
Enterprise Value Multiple -1.60